CDH17 and neoplasm: We conclude from these findings that (i) additional mutations in most of the known HGSC driver genes apparently are not required for the acquisition of metastatic properties, and (ii) alterations in FAT3 may contribute to the metastatic spread in a subset of patients, consistent with its function as an atypical cadherin and its known tumor‐suppressive potential.